| 2026-09-29 | Results | Results posted: A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Mult | Trial register ClinicalTrials.gov |
| 2026-09-15 | Results | Results posted: Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2026-08-13 | Trial | New trial registered: Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2026-07-27 | Trial | New trial registered: A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults | Trial register ClinicalTrials.gov |
| 2026-07-21 | Trial | New trial registered: Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy | Trial register ClinicalTrials.gov |
| 2026-07-17 | Trial | New trial registered: A Single-center, Prospective, Single-arm Clinical Study Exploring the Treatment of Newly Diagnosed Multiple Myeloma Patients With t(11;14) Suitable | Trial register ClinicalTrials.gov |
| 2026-06-30 | Trial | New trial registered: Real-World Clinical Outcomes in Relapsed/Refractory Multiple Myeloma Treated With Pomalidomide Regimens | Trial register ClinicalTrials.gov |
| 2026-06-17 | Trial | New trial registered: KCD (Carfilzomib/Cyclophosphamide/Dexamethasone) Regimen for the Treatment of Newly Diagnosed POEMS Syndrome | Trial register ClinicalTrials.gov |
| 2026-05-29 | Results | Results posted: A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2026-05-26 | Trial | New trial registered: Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial | Trial register ClinicalTrials.gov |
| 2026-04-29 | Trial | New trial registered: Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2026-03-20 | Results | Results posted: A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Mye | Trial register ClinicalTrials.gov |
| 2026-03-18 | Trial | New trial registered: Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2026-03-11 | Trial | New trial registered: Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and D | Trial register ClinicalTrials.gov |
| 2026-03-06 | Results | Results posted: Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2026-02-10 | Results | Results posted: Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2026-02-06 | Trial | New trial registered: A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Re | Trial register ClinicalTrials.gov |
| 2026-01-16 | Trial | New trial registered: A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Mul | Trial register ClinicalTrials.gov |
| 2025-11-20 | Results | Results posted: High Dose Carfilzomib for Newly Diagnosed Myeloma | Trial register ClinicalTrials.gov |
| 2025-11-12 | Trial | New trial registered: A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Mu | Trial register ClinicalTrials.gov |
| 2025-10-30 | Trial | New trial registered: A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult | Trial register ClinicalTrials.gov |
| 2025-09-10 | Results | Results posted: Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2025-08-06 | Results | Results posted: A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2025-07-24 | Trial | New trial registered: Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2025-06-18 | Label | FDA label revised: KYPROLIS (NDA202714) | Regulator FDA drug label register |
| 2025-06-09 | Trial | New trial registered: Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies | Trial register ClinicalTrials.gov |
| 2025-06-04 | Results | Results posted: Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia | Trial register ClinicalTrials.gov |
| 2025-05-02 | Results | Results posted: Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2025-04-29 | Trial | New trial registered: Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexame | Trial register ClinicalTrials.gov |
| 2025-04-09 | Trial | New trial registered: Treatment of Antibody-Mediated Rejection (ABMR) With CarBel | Trial register ClinicalTrials.gov |
| 2025-03-29 | Trial | New trial registered: Efficacy of Sequential BCMA CAR-T Cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in Transplant-eligible Newly Diagnosed M | Trial register ClinicalTrials.gov |
| 2025-03-24 | Trial | New trial registered: A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-s | Trial register ClinicalTrials.gov |
| 2025-03-17 | Trial | New trial registered: KPD Consolidation After ASCT in NDMM Patients | Trial register ClinicalTrials.gov |
| 2025-01-27 | Trial | New trial registered: Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease | Trial register ClinicalTrials.gov |
| 2025-01-19 | Trial | New trial registered: Immunotherapy in Lymphoma | Trial register ClinicalTrials.gov |
| 2024-11-12 | Trial | New trial registered: Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients | Trial register ClinicalTrials.gov |
| 2024-10-04 | Trial | New trial registered: Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease | Trial register ClinicalTrials.gov |
| 2024-10-01 | Trial | New trial registered: SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2024-09-26 | Trial | New trial registered: A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide | Trial register ClinicalTrials.gov |
| 2024-09-19 | Results | Results posted: Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2024-08-23 | Trial | New trial registered: Right Ventricular Function in Patients Taking Carfilzomib | Trial register ClinicalTrials.gov |
| 2024-08-07 | Trial | New trial registered: Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone | Trial register ClinicalTrials.gov |
| 2024-08-05 | Trial | New trial registered: ATRA and Carfilzomib in Plasma Cell Myeloma Patients | Trial register ClinicalTrials.gov |
| 2024-07-26 | Results | Results posted: Phase I: Melphalan, Bendamustine and Carfilzomib for Autologous Transplant in Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2024-07-16 | Results | Results posted: Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2024-05-29 | Results | Results posted: Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma | Trial register ClinicalTrials.gov |
| 2024-05-14 | Trial | New trial registered: A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2024-05-10 | Trial | New trial registered: Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection | Trial register ClinicalTrials.gov |
| 2024-05-09 | Results | Results posted: Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients | Trial register ClinicalTrials.gov |
| 2024-04-18 | Results | Results posted: A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multi | Trial register ClinicalTrials.gov |
| 2024-04-10 | Trial | New trial registered: A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or R | Trial register ClinicalTrials.gov |
| 2024-04-05 | Results | Results posted: LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2024-04-04 | Results | Results posted: Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas | Trial register ClinicalTrials.gov |
| 2024-02-08 | Trial | New trial registered: Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer | Trial register ClinicalTrials.gov |
| 2024-01-31 | Trial | New trial registered: A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Mye | Trial register ClinicalTrials.gov |
| 2024-01-02 | Results | Results posted: Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2023-12-21 | Trial | New trial registered: A Clinical Study on the Whole-course Management (BCD-KPD-AutoHSCT) Scheme for Patients With RIMM | Trial register ClinicalTrials.gov |
| 2023-12-19 | Results | Results posted: Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab | Trial register ClinicalTrials.gov |
| 2023-12-06 | Trial | New trial registered: Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refrac | Trial register ClinicalTrials.gov |
| 2023-11-30 | Trial | New trial registered: MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Oth | Trial register ClinicalTrials.gov |
| 2023-11-22 | Results | Results posted: Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2023-11-22 | Trial | New trial registered: All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2023-11-21 | Trial | New trial registered: Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, U | Trial register ClinicalTrials.gov |
| 2023-11-08 | Results | Results posted: Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet | Trial register ClinicalTrials.gov |
| 2023-10-26 | Results | Results posted: KRDI in Transplant-Eligible MM | Trial register ClinicalTrials.gov |
| 2023-09-26 | Trial | New trial registered: A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractor | Trial register ClinicalTrials.gov |
| 2023-06-18 | Trial | New trial registered: Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM | Trial register ClinicalTrials.gov |
| 2023-06-09 | Trial | New trial registered: Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2023-03-29 | Trial | New trial registered: Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2023-02-13 | Results | Results posted: Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple My | Trial register ClinicalTrials.gov |
| 2023-01-30 | Trial | New trial registered: A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refracto | Trial register ClinicalTrials.gov |
| 2023-01-09 | Trial | New trial registered: A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myel | Trial register ClinicalTrials.gov |
| 2023-01-09 | Trial | New trial registered: Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After Fir | Trial register ClinicalTrials.gov |
| 2023-01-03 | Trial | New trial registered: International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab | Trial register ClinicalTrials.gov |
| 2022-12-23 | Results | Results posted: Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2022-12-15 | Trial | New trial registered: A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2022-11-17 | Trial | New trial registered: Home Treatment With Carfilzomib in Patients With Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2022-10-07 | Trial | New trial registered: A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants Wi | Trial register ClinicalTrials.gov |
| 2022-09-27 | Trial | New trial registered: A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2022-09-23 | Results | Results posted: Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2022-09-23 | Trial | New trial registered: A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants | Trial register ClinicalTrials.gov |
| 2022-08-22 | Results | Results posted: A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Mul | Trial register ClinicalTrials.gov |
| 2022-08-22 | Trial | New trial registered: Phase II Study of Carfilzomib, Pomalidomide, and Dexamethasone for Myeloma Patients Who Had Relapsed or Progressed After Carfilzomib, Lenalidomide, | Trial register ClinicalTrials.gov |
| 2022-08-11 | Trial | New trial registered: Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial | Trial register ClinicalTrials.gov |
| 2022-08-11 | Trial | New trial registered: Carfilzomib, Lenalidomide, and Dexamethasone Re-induction Followed by the 2nd ASCT in Multiple Myeloma Patients Relapsed After the 1st ASCT | Trial register ClinicalTrials.gov |
| 2022-08-10 | Trial | New trial registered: Long-term KRd in Relapsed and/or Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2022-07-26 | Results | Results posted: LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2022-07-01 | Results | Results posted: Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers | Trial register ClinicalTrials.gov |
| 2022-06-29 | Trial | New trial registered: A Study of Daratumumab | Trial register ClinicalTrials.gov |
| 2022-06-28 | Trial | New trial registered: COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide | Trial register ClinicalTrials.gov |
| 2022-05-09 | Results | Results posted: Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2022-04-25 | Results | Results posted: Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation | Trial register ClinicalTrials.gov |
| 2022-04-13 | Results | Results posted: A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531 | Trial register ClinicalTrials.gov |
| 2022-02-02 | Results | Results posted: Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2022-01-20 | Trial | New trial registered: Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2022-01-12 | Results | Results posted: A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens | Trial register ClinicalTrials.gov |
| 2022-01-11 | Trial | New trial registered: Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib | Trial register ClinicalTrials.gov |
| 2021-12-21 | Results | Results posted: Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma | Trial register ClinicalTrials.gov |
| 2021-11-30 | Trial | New trial registered: A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myelo | Trial register ClinicalTrials.gov |
| 2021-09-29 | Trial | New trial registered: Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide | Trial register ClinicalTrials.gov |